ArticleAIDS and behavior2025
The Trend in Suicide Risk Among People with HIV Before, During, and After the COVID-19 Pandemic Lockdown.
Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Suicide Risk (SR) and the COVID-19 pandemic affected People with HIV (PWH) disproportionately in comparison with the general population, but little information on SR during and after the COVID-19 lockdown on the Latino PWH has been described, therefore, this study aimed to describe SR in PWH attended the HIV clinic before (2018-2019), during (2020), and after (2021-2022) the COVID-19 lockdown, the trend of SR, and the factors associated. Three standardized questions from the "Columbia-Suicide Severity Rating Scale" (C-SSRS) were routinely applied as screening for suicide risk to all PWH attending their clinical visits during 2018-2022. We estimated suicidality risk and rate. We compared sociodemographic characteristics in those with and without SR. We evaluated the potential association of SR with the calendar year before, during, and after the COVID-19 lockdown using a mixed-effects logistic regression. A total of 2330 patients were seen during the study period; 2157 (93%) were evaluated for suicidality at least once, of those, 75 (3.5%) had SR. Those with SR compared with non-SR were more frequently women (20% vs 10%) and with a heterosexual HIV transmission route (29% vs 23%). SR rates per 1000 patients-day among those evaluated were 0.03 in 2018, 0.25 in 2019, 3.16 in 2020, 7.0 in 2021 and 11.98 in 2022. Throughout the model, independently of covariables, a significant increase in the OR of SR was observed in these years compared to 2018: 1.07 in 2019; 2.74 in 2021; and 4.82 in 2022, except in 2020, OR = 0.18.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.